Delivery Order SPE2DX15D6028-SPE2DX23FWPBA
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,472.21, is for the supply of Malarone 250/100 100S, a pharmaceutical product, with a performance period through April 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,299.70, is for the delivery of 4,562,865,028 units of Malarone 250-100 mg tablets in 100-count packages. The contract has an ultimate completion date of November 21, 2023 and is structured as a firm fixed-price delivery order. This award is part of AmerisourceBergen's...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MALARONE 250/100 100S medication. The contract has a firm fixed price of $9,088.04 and a completion date of July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Malarone 250/100 100s medication. The contract has a ceiling value of $12,088.44 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,114.63, is for the delivery of Malarone 62.5-25 mg pediatric tablets, a medication used to prevent and treat malaria. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 1, 2024. Amerisourcebergen also holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,373.56, is for the delivery of MALARONE 250/100 100S, a pharmaceutical product, to support federal medical programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $134,705.05, is for the delivery of MALARONE 250/100 100S, a medication used to prevent and treat malaria. The contract is a firm fixed-price arrangement with a completion date of October 21, 2015. This award is not designated as a set-aside contract. Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,492.22, is for the delivery of Malarone 62.5-25 mg pediatric tablets in packages of 100. The order has a firm fixed price and a completion date of July 17, 2024. Amerisourcebergen is a large pharmaceutical distributor that holds multiple Indefinite Delivery Contracts...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Malarone 250-100 mg tablets. The $2,272.56 firm fixed-price delivery order has a completion date of May 1, 2023. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $4,303.64. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DX15D6028Indefinite Delivery Contract
- SPE2DX15D6028-SPE2DX23FWPBADelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,815.72, is for the delivery of Malarone 62.5-25mg medication and is a firm fixed-price contract type. The award has no set-aside designation, indicating open competition. The contract is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/19/23 |